Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078133371> ?p ?o ?g. }
- W2078133371 endingPage "6199" @default.
- W2078133371 startingPage "6190" @default.
- W2078133371 abstract "The antimalarial compound fosmidomycin targets DXR, the enzyme that catalyzes the first committed step in the MEP pathway, producing the essential isoprenoid precursors, isopentenyl diphosphate and dimethylallyl diphosphate. The MEP pathway is used by a number of pathogens, including Mycobacterium tuberculosis and apicomplexan parasites, and differs from the classical mevalonate pathway that is essential in humans. Using a structure-based approach, we designed a number of analogues of fosmidomycin, including a series that are substituted in both the Cα and the hydroxamate positions. The latter proved to be a stable framework for the design of inhibitors that extend from the polar and cramped (and so not easily druggable) substrate-binding site and can, for the first time, bridge the substrate and cofactor binding sites. A number of these compounds are more potent than fosmidomycin in terms of killing Plasmodium falciparum in an in vitro assay; the best has an IC50 of 40 nM." @default.
- W2078133371 created "2016-06-24" @default.
- W2078133371 creator A5008347976 @default.
- W2078133371 creator A5011119491 @default.
- W2078133371 creator A5018815339 @default.
- W2078133371 creator A5022273450 @default.
- W2078133371 creator A5022965126 @default.
- W2078133371 creator A5027829632 @default.
- W2078133371 creator A5037772659 @default.
- W2078133371 creator A5040096932 @default.
- W2078133371 creator A5051132348 @default.
- W2078133371 creator A5052475184 @default.
- W2078133371 creator A5054783399 @default.
- W2078133371 creator A5066622264 @default.
- W2078133371 creator A5069171891 @default.
- W2078133371 creator A5069299314 @default.
- W2078133371 creator A5071172712 @default.
- W2078133371 creator A5071764167 @default.
- W2078133371 creator A5074394337 @default.
- W2078133371 creator A5078479217 @default.
- W2078133371 date "2013-07-17" @default.
- W2078133371 modified "2023-09-23" @default.
- W2078133371 title "DXR Inhibition by Potent Mono- and Disubstituted Fosmidomycin Analogues" @default.
- W2078133371 cites W1970058276 @default.
- W2078133371 cites W1972401663 @default.
- W2078133371 cites W1973148945 @default.
- W2078133371 cites W1976725431 @default.
- W2078133371 cites W1976826704 @default.
- W2078133371 cites W1977444198 @default.
- W2078133371 cites W1978388528 @default.
- W2078133371 cites W1998555588 @default.
- W2078133371 cites W2001641653 @default.
- W2078133371 cites W2008872195 @default.
- W2078133371 cites W2013083986 @default.
- W2078133371 cites W2013604287 @default.
- W2078133371 cites W2023372492 @default.
- W2078133371 cites W2025785709 @default.
- W2078133371 cites W2032881444 @default.
- W2078133371 cites W2038840577 @default.
- W2078133371 cites W2038914330 @default.
- W2078133371 cites W2042353065 @default.
- W2078133371 cites W2047619191 @default.
- W2078133371 cites W2047745904 @default.
- W2078133371 cites W2050085208 @default.
- W2078133371 cites W2050172943 @default.
- W2078133371 cites W2072548107 @default.
- W2078133371 cites W2073920564 @default.
- W2078133371 cites W2080616046 @default.
- W2078133371 cites W2083602661 @default.
- W2078133371 cites W2087057175 @default.
- W2078133371 cites W2093637194 @default.
- W2078133371 cites W2095445547 @default.
- W2078133371 cites W2110893691 @default.
- W2078133371 cites W2128951621 @default.
- W2078133371 cites W2131639373 @default.
- W2078133371 cites W2133350645 @default.
- W2078133371 cites W2142251083 @default.
- W2078133371 cites W2143243315 @default.
- W2078133371 cites W2145018290 @default.
- W2078133371 cites W2145600860 @default.
- W2078133371 cites W2163341755 @default.
- W2078133371 cites W2164267446 @default.
- W2078133371 cites W2179992848 @default.
- W2078133371 cites W2272525520 @default.
- W2078133371 cites W2336713297 @default.
- W2078133371 cites W4210675630 @default.
- W2078133371 doi "https://doi.org/10.1021/jm4006498" @default.
- W2078133371 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23819803" @default.
- W2078133371 hasPublicationYear "2013" @default.
- W2078133371 type Work @default.
- W2078133371 sameAs 2078133371 @default.
- W2078133371 citedByCount "27" @default.
- W2078133371 countsByYear W20781333712014 @default.
- W2078133371 countsByYear W20781333712015 @default.
- W2078133371 countsByYear W20781333712016 @default.
- W2078133371 countsByYear W20781333712017 @default.
- W2078133371 countsByYear W20781333712018 @default.
- W2078133371 countsByYear W20781333712019 @default.
- W2078133371 countsByYear W20781333712020 @default.
- W2078133371 countsByYear W20781333712021 @default.
- W2078133371 countsByYear W20781333712022 @default.
- W2078133371 countsByYear W20781333712023 @default.
- W2078133371 crossrefType "journal-article" @default.
- W2078133371 hasAuthorship W2078133371A5008347976 @default.
- W2078133371 hasAuthorship W2078133371A5011119491 @default.
- W2078133371 hasAuthorship W2078133371A5018815339 @default.
- W2078133371 hasAuthorship W2078133371A5022273450 @default.
- W2078133371 hasAuthorship W2078133371A5022965126 @default.
- W2078133371 hasAuthorship W2078133371A5027829632 @default.
- W2078133371 hasAuthorship W2078133371A5037772659 @default.
- W2078133371 hasAuthorship W2078133371A5040096932 @default.
- W2078133371 hasAuthorship W2078133371A5051132348 @default.
- W2078133371 hasAuthorship W2078133371A5052475184 @default.
- W2078133371 hasAuthorship W2078133371A5054783399 @default.
- W2078133371 hasAuthorship W2078133371A5066622264 @default.
- W2078133371 hasAuthorship W2078133371A5069171891 @default.
- W2078133371 hasAuthorship W2078133371A5069299314 @default.
- W2078133371 hasAuthorship W2078133371A5071172712 @default.